Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 Condition
Yan Xie, Taeyoung Choi, Ziyad Al‐Aly
JAMA Internal Medicine (2023) Vol. 183, Iss. 6, pp. 554-554
Open Access | Times Cited: 219

Showing 1-25 of 219 citing articles:

Postacute sequelae of COVID-19 at 2 years
Benjamin Bowe, Yan Xie, Ziyad Al‐Aly
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2347-2357
Open Access | Times Cited: 233
Long COVID science, research and policy
Ziyad Al‐Aly, Hannah Davis, Lisa McCorkell, et al.
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2148-2164
Open Access | Times Cited: 120
Long COVID: a clinical update
Trisha Greenhalgh, Manoj Sivan, Alice Perlowski, et al.
The Lancet (2024) Vol. 404, Iss. 10453, pp. 707-724
Closed Access | Times Cited: 97
Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras
Yan Xie, Taeyoung Choi, Ziyad Al‐Aly
New England Journal of Medicine (2024) Vol. 391, Iss. 6, pp. 515-525
Closed Access | Times Cited: 87
Molnupiravir and risk of post-acute sequelae of covid-19: cohort study
Yan Xie, Taeyoung Choi, Ziyad Al‐Aly
BMJ (2023), pp. e074572-e074572
Open Access | Times Cited: 82
Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study
Yan Xie, Taeyoung Choi, Ziyad Al‐Aly
The Lancet Infectious Diseases (2023) Vol. 24, Iss. 3, pp. 239-255
Open Access | Times Cited: 74
Solving the puzzle of Long Covid
Ziyad Al‐Aly, Eric J. Topol
Science (2024) Vol. 383, Iss. 6685, pp. 830-832
Closed Access | Times Cited: 69
Cardiovascular autonomic dysfunction in post-COVID-19 syndrome: a major health-care burden
Artur Fedorowski, Alessandra Fanciulli, Satish R. Raj, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 6, pp. 379-395
Closed Access | Times Cited: 57
Nirmatrelvir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records
Yan Xie, Benjamin Bowe, Ziyad Al‐Aly
BMJ (2023), pp. e073312-e073312
Open Access | Times Cited: 55
SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic
Fotini Boufidou, Snežana Medić, Vicky Lampropoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12962-12962
Open Access | Times Cited: 51
Long COVID: Costs for the German economy and health care and pension system
Afschin Gandjour
BMC Health Services Research (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 44
Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection
Linda N. Geng, Hector Bonilla, Haley Hedlin, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 9, pp. 1024-1024
Open Access | Times Cited: 39
Mechanisms of long COVID and the path toward therapeutics
Michael J. Peluso, Steven G. Deeks
Cell (2024)
Open Access | Times Cited: 39
Association of nirmatrelvir for acute SARS‐CoV‐2 infection with subsequent Long COVID symptoms in an observational cohort study
Matthew S. Durstenfeld, Michael J. Peluso, Feng Lin, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Open Access | Times Cited: 32
Mapping the effectiveness and risks of GLP-1 receptor agonists
Yan Xie, Taeyoung Choi, Ziyad Al‐Aly
Nature Medicine (2025)
Closed Access | Times Cited: 23
Pathophysiological, immunological, and inflammatory features of long COVID
Karen Böhmwald, Benjamín Diethelm‐Varela, Linmar Rodríguez-Guilarte, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 21
Cardiovascular disease as part of Long COVID: a systematic review
Vasiliki Tsampasian, Maria Bäck, Marco Bernardi, et al.
European Journal of Preventive Cardiology (2024)
Open Access | Times Cited: 19
Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
Alison K. Cohen, Toni Wall Jaudon, Eric M. Schurman, et al.
Communications Medicine (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 2
Real-world evidence of remdesivir in formerly hospitalized COVID-19 patients: patient-reported and functional outcomes
Dorottya Fésü, Enikő Bárczi, Balázs Csoma, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Targeting the SARS-CoV-2 reservoir in long COVID
Amy D. Proal, Soo Aleman, Morgane Bomsel, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 2
Nirmatrelvir–ritonavir versus placebo–ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial
Mitsuaki Sawano, Bornali Bhattacharjee, César Caraballo, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 2
Tissue‐resident memory T cells and lung immunopathology
In Su Cheon, Young Min Son, Jie Sun
Immunological Reviews (2023) Vol. 316, Iss. 1, pp. 63-83
Open Access | Times Cited: 36
Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection
Annukka A.R. Antar, Tong Yu, Zoe O Demko, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10458-10458
Open Access | Times Cited: 33
Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies
Danilo Buonsenso, Laura Martino, Rosa Morello, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 9, pp. e745-e756
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top